Skip to content
Screener

LivaNova LIVN Operating Income

Operating Income at other companies

Abbott logo
AbbottABT
$1.69B-17.5%
Haemonetics logo
HaemoneticsHAE
$57.46M+6.7%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-$5.57M-8.2%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
-$1.12M+24.7%
Medtronic logo
MedtronicMDT
$1.87B+30.4%
ITG
Integer HoldingsITGR
$31.87M-35.7%

Segments

By segment

See full
Neuromodulation$60.94M+8.8%
Cardiopulmonary$28.15M-10.4%

Other financials

Income statement

See full
Revenue$390.6M+10.8%
Gross profit$273.7M+14.5%
Net income$108.6M+300%
EPS (diluted)$1.93+286%

Balance sheet

See full
Cash & equivalents$516.6M-13.0%
Total debt$348.5M-27.8%
Total equity$1.3B+18.0%
Total assets$2.6B+5.4%

Cash flow

See full
Operating cash flow$66.6M+5.8%
CapEx$31.6M+108%
Free cash flow$35.0M-26.7%

Valuation

See full
Market cap$4.17B+61.5%
Enterprise value$4.01B+61.9%
P/E22.6×-67.9×
P/S2.8×+0.9×

Profitability

See full
Gross margin68.1%+0.1pp
Operating margin12.7%-0.7pp
Net margin-16.1%-18.0pp
FCF margin10.1%-2.3pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.2×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: LivaNova’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 2:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001639691-26-000090
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Selling, general, and administrative158,128137,780301,696266,926
Research and development53,66247,185112,35785,064
Other operating expense12,396(160)12,411452
Operating income49,48454,18390,955102,800
SNIA environmental liability expense(1,677)(362,070)
Interest expense(7,176)(14,931)(15,467)(30,217)
Foreign exchange and other income/(expense)(23,829)(4,255)(29,524)7,161
Income (loss) before income tax18,47933,32045,964(282,326)

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is LivaNova's operating income?
LivaNova (LIVN) reported operating income of $49.48M in Q2 2026.
How has LivaNova's operating income changed year-over-year?
LivaNova's operating income decreased by 8.7% year-over-year, from $54.18M to $49.48M.
What is the long-term trend for LivaNova's operating income?
Over 3 years (2021 to 2025), LivaNova's operating income has grown at a 533.6% compound annual growth rate (CAGR), from -$784K to $199.39M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Ask your AI about LivaNova's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude